Consolidated Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7264782

Concept 2024-10-01 to
2025-03-31
As at
2025-03-31
As at
2024-09-30
2023-10-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,921,000,000 JPY
149,000,000 JPY
Interest and dividends received
3,000,000 JPY
2,000,000 JPY
Interest paid
-139,000,000 JPY
-81,000,000 JPY
Income taxes paid
-1,654,000,000 JPY
-516,000,000 JPY
Net cash provided by (used in) operating activities
2,131,000,000 JPY
-445,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-665,000,000 JPY
-1,884,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
1,000,000 JPY
Net cash provided by (used in) investing activities
-2,764,000,000 JPY
1,457,000,000 JPY
Proceeds from sale of investment securities
JPY
5,356,000,000 JPY
Other, net
106,000,000 JPY
66,000,000 JPY
Cash flows from financing activities
Dividends paid
-547,000,000 JPY
-432,000,000 JPY
Proceeds from issuance of bonds
986,000,000 JPY
JPY
Proceeds from long-term borrowings
9,000,000,000 JPY
JPY
Repayments of long-term borrowings
-6,300,000,000 JPY
-3,810,000,000 JPY
Redemption of bonds
-300,000,000 JPY
-300,000,000 JPY
Net cash provided by (used in) financing activities
2,750,000,000 JPY
-1,998,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-7,000,000 JPY
37,000,000 JPY
Net increase (decrease) in cash and cash equivalents
2,109,000,000 JPY
-948,000,000 JPY
Cash and cash equivalents
6,695,000,000 JPY
4,585,000,000 JPY
1,375,000,000 JPY
2,324,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.